Esther Manzano-Navarro
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Journal: Nature cancer
Published: July 23, 2025
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes.
Journal: Breast cancer research and treatment
Published: October 30, 2023
Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer.
Journal: Cancers
Published: April 14, 2023
A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients.
Journal: Frontiers in oncology
Published: March 09, 2023
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Journal: Nature immunology
Published: December 07, 2019
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 23, 2019
Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables.
Journal: Scientific reports
Published: February 28, 2019
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis.
Journal: Breast cancer research and treatment
Published: November 12, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026